Who owns CASI PHARMACEUTICALS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Casi Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Casi Pharmaceuticals stock

Who bought or sold CASI PHARMACEUTICALS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
VR Adviser 987k $2.8M 0% Dec 2024
 View chart
Woodline Partners 100k $282k 227% Dec 2024
 View chart
Wellington Shields Capital Management 86k $243k -4% Dec 2024
 View chart
ADAR1 Capital Management 65k $399k 687% Sep 2024
 View chart
Renaissance Technologies 39k $112k -5% Dec 2024
 View chart
Wellington Shields & Co 30k $85k -30% Dec 2024
 View chart
Geode Capital Management 19k $55k 0% Dec 2024
 View chart
UBS Group 11k $32k -23% Dec 2024
 View chart
Royal Bank of Canada 6.9k $20k 0% Dec 2024
 View chart
Morgan Stanley 1.5k $4.2k 3% Dec 2024
 View chart
Wells Fargo & Company 505.00 $1.4k 0% Dec 2024
 View chart
BlackRock 296.00 $838.005600 0% Dec 2024
 View chart
Bnp Paribas Arbitrage, Snc 134.00 $379.005600 100% Dec 2024
 View chart
West Paces Advisors 100.00 $283.000000 0% Dec 2024
 View chart
Bank of America Corporation 28.00 $78.999200 0% Dec 2024
 View chart
Jpmorgan Chase & Co 25.00 $71.000000 0% Dec 2024
 View chart
Northwestern Mutual Wealth Management Company 13.00 $37.000600 0% Dec 2024
 View chart
Colonial Trust Co / SC 11.00 $67.999800 100% Sep 2024
 View chart
Trust Co Of Vermont 10.00 $28.000000 0% Dec 2024
 View chart
MAI Wealth Advisors 5.00 $15.000000 100% Dec 2024
 View chart
Wingate Wealth Advisors 2.00 $6.000000 100% Dec 2024
 View chart

Who sold out of Casi Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
Citadel Advisors Sep 2024 25k $146k
Advisor Group Holdings Sep 2024 8.00 $49.000000
Catalyst Funds Management Pty Jun 2024 8.00 $44.000000